Gastroenteritis (Rotavirus)

Overview


Plain-Language Overview

Gastroenteritis (Rotavirus) is an infection that affects the stomach and intestines, causing inflammation. It primarily affects young children and leads to symptoms like diarrhea, vomiting, and fever. The infection spreads easily through contaminated hands, surfaces, or food. This condition can cause dehydration due to fluid loss, which is the main health concern. The illness usually lasts for a few days but can be severe in infants and young children. Good hygiene and sanitation are important to prevent its spread.

Clinical Definition

Gastroenteritis (Rotavirus) is an acute inflammatory condition of the gastrointestinal tract caused by infection with rotavirus, a double-stranded RNA virus of the Reoviridae family. It primarily affects infants and young children worldwide and is a leading cause of severe diarrheal disease and dehydration in this population. The virus infects and destroys mature enterocytes in the small intestine, leading to malabsorption and osmotic diarrhea. Clinical features include watery diarrhea, vomiting, fever, and abdominal pain. The disease is highly contagious and transmitted via the fecal-oral route. Diagnosis is important due to the risk of severe dehydration and electrolyte imbalance.

Inciting Event

  • Fecal-oral ingestion of rotavirus particles from contaminated hands, surfaces, or food.

  • Close contact with infected individuals in households or daycare centers.

  • Outbreaks in community settings during rotavirus season.

Latency Period

  • Symptoms typically develop 1 to 3 days after exposure to rotavirus.

  • Viral replication in enterocytes occurs during the incubation period before symptom onset.

Diagnostic Delay

  • Symptoms often resemble other viral or bacterial gastroenteritis, leading to initial misdiagnosis.

  • Lack of routine rotavirus antigen testing delays specific diagnosis.

  • Mild cases may not seek medical attention, causing underdiagnosis.

Clinical Presentation


Signs & Symptoms

  • Watery diarrhea lasting 3-8 days

  • Vomiting often preceding diarrhea

  • Fever usually low-grade

  • Abdominal cramps and irritability

  • Dehydration symptoms such as dry mouth and decreased urine output

History of Present Illness

  • Abrupt onset of profuse watery diarrhea lasting 3 to 8 days.

  • Vomiting and low-grade fever often precede diarrhea.

  • Signs of dehydration such as dry mucous membranes and lethargy develop with ongoing fluid loss.

  • Stools are typically non-bloody and without leukocytes.

  • Symptoms peak within the first 2 to 3 days and gradually resolve.

Past Medical History

  • Incomplete or absent rotavirus vaccination increases risk of severe disease.

  • History of prematurity or immunodeficiency may worsen clinical course.

  • Previous episodes of gastroenteritis may indicate susceptibility.

Family History

  • No significant heritable predisposition to rotavirus infection.

  • Family members often share exposure due to close contact and hygiene practices.

Physical Exam Findings

  • Signs of dehydration including dry mucous membranes, decreased skin turgor, and sunken eyes

  • Tachycardia and hypotension in severe dehydration

  • Abdominal tenderness without peritoneal signs

  • Lethargy or irritability in infants and young children

Diagnostic Workup


Diagnostic Criteria

Diagnosis of gastroenteritis caused by rotavirus is established by detecting rotavirus antigen in stool samples using enzyme immunoassay (EIA) or latex agglutination tests. Clinical presentation with acute onset of watery diarrhea, vomiting, and fever in a young child supports the diagnosis. Stool PCR can be used for confirmation and genotyping but is less commonly required. Identification of rotavirus excludes other causes of viral gastroenteritis and guides epidemiologic management.

Pathophysiology


Key Mechanisms

  • Infection of mature enterocytes in the small intestine by rotavirus leads to villous atrophy and malabsorption.

  • NSP4 enterotoxin produced by rotavirus increases intracellular calcium, causing secretory diarrhea.

  • Damage to the intestinal epithelium results in decreased disaccharidase activity, contributing to osmotic diarrhea.

  • Activation of the enteric nervous system enhances intestinal motility and fluid secretion.

  • Loss of absorptive surface area causes dehydration and electrolyte imbalances.

InvolvementDetails
Organs

Small intestine is the main organ affected by rotavirus, leading to diarrhea and malabsorption.

Liver may be involved in systemic immune responses but is not directly infected by rotavirus.

Tissues

Small intestinal mucosa is the primary site of rotavirus infection causing villous atrophy and impaired absorption.

Lamina propria contains immune cells that respond to viral infection and mediate inflammation.

Cells

Enterocytes in the small intestinal villi are infected by rotavirus, leading to malabsorption and secretory diarrhea.

Goblet cells increase mucus secretion in response to infection, contributing to diarrhea.

Immune cells including dendritic cells and macrophages initiate the antiviral immune response in the intestinal mucosa.

Chemical Mediators

NSP4 enterotoxin produced by rotavirus disrupts enterocyte function and increases chloride secretion causing secretory diarrhea.

Interferons are released by infected cells to limit viral replication and activate immune responses.

Proinflammatory cytokines such as IL-6 and TNF-alpha contribute to mucosal inflammation and symptoms.

Treatments


Pharmacological Treatments

Non-pharmacological Treatments

  • Oral rehydration therapy with balanced electrolyte solutions is the cornerstone of managing rotavirus gastroenteritis to prevent dehydration.

  • Breastfeeding should be continued during illness to provide immune factors and maintain nutrition.

  • Zinc supplementation can reduce the duration and severity of diarrhea in children with rotavirus infection.

  • Hospitalization with intravenous fluids is necessary for severe dehydration or inability to tolerate oral intake.

Prevention


Pharmacological Prevention

  • Oral rotavirus vaccines (e.g., RotaTeq, Rotarix) administered in infancy to prevent infection

Non-pharmacological Prevention

  • Hand hygiene with soap and water to reduce fecal-oral transmission

  • Breastfeeding to provide passive immunity and reduce severity

  • Safe water and sanitation practices to limit environmental contamination

  • Isolation of infected individuals during outbreaks to prevent spread

Outcome & Complications


Complications

  • Severe dehydration leading to hypovolemic shock

  • Electrolyte imbalances such as hyponatremia or hypokalemia

  • Secondary bacterial infections due to mucosal damage

  • Intussusception rarely associated with rotavirus infection

Short-term Sequelae Long-term Sequelae
  • Acute kidney injury from volume depletion

  • Hospitalization for intravenous fluid resuscitation

  • Nutritional deficits due to decreased intake and malabsorption

  • Post-infectious lactose intolerance due to villous atrophy

  • Growth retardation in children with repeated or severe infections

  • No chronic viral persistence or long-term organ damage typically occurs

Differential Diagnoses


Gastroenteritis (Rotavirus) versus Norovirus Gastroenteritis

Gastroenteritis (Rotavirus)

Norovirus Gastroenteritis

Primarily affects infants and young children under 5 years

Affects all age groups including adults

Caused by a double-stranded RNA virus from the Reoviridae family

Caused by a single-stranded RNA virus from the Caliciviridae family

Commonly transmitted via fecal-oral route in daycare centers and pediatric settings

Often associated with outbreaks on cruise ships and closed communities

Gastroenteritis (Rotavirus) versus Bacterial Gastroenteritis (e.g., Salmonella, Shigella)

Gastroenteritis (Rotavirus)

Bacterial Gastroenteritis (e.g., Salmonella, Shigella)

No fecal leukocytes; stool antigen or PCR positive for viral RNA

Presence of fecal leukocytes and positive stool cultures for bacteria

Typically causes watery, non-bloody diarrhea with low-grade or no fever

Often presents with bloody diarrhea and high fever

Managed primarily with supportive care and hydration

Requires antibiotics in severe cases

Gastroenteritis (Rotavirus) versus Giardiasis

Gastroenteritis (Rotavirus)

Giardiasis

Caused by a viral pathogen

Caused by the protozoan Giardia lamblia

Acute onset of watery diarrhea without malabsorption

Chronic diarrhea with malabsorption and steatorrhea

Detection of viral antigen or RNA in stool by ELISA or PCR

Detection of cysts or trophozoites in stool by microscopy or antigen testing

Gastroenteritis (Rotavirus) versus Enteric Adenovirus Gastroenteritis

Gastroenteritis (Rotavirus)

Enteric Adenovirus Gastroenteritis

Primarily affects infants and young children under 5 years

Common in children under 2 years but can affect older children

Usually self-limited diarrhea lasting 3-8 days

Longer duration of diarrhea (7-10 days) compared to typical viral gastroenteritis

Detection of rotavirus antigen or RNA in stool

Detection of adenovirus antigen or DNA in stool

Gastroenteritis (Rotavirus) versus Clostridioides difficile Infection

Gastroenteritis (Rotavirus)

Clostridioides difficile Infection

No recent antibiotic exposure; community-acquired

Recent antibiotic use or hospitalization

Causes mild to moderate watery diarrhea without colitis

Often causes severe, sometimes bloody diarrhea with pseudomembranous colitis

Negative for bacterial toxins; positive for viral antigen or RNA

Positive stool toxin assay for C. difficile toxins

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.